ABOUT JUYMO
Designed for Execution
JUYMO was created to bring senior leadership, execution continuity, and AI-enabled delivery together in a modern execution model for life sciences.
JUYMO is built around experienced leaders staying close to the work.
Why JUYMO Exists
Life sciences organizations often have strong strategic intent but struggle to maintain continuity between decisions and execution. JUYMO was built to close that gap.
The model combines senior executive expertise, lean operating structures, and AI-enabled delivery, bringing the right capabilities together around each organization’s specific challenge.
- Senior expertise stays connected to execution
- Continuity from strategy through implementation
- Direct involvement from experienced leaders
- Clear governance and accountability
- Practical execution support
- AI-enabled delivery
EXECUTIVE PARTNER NETWORK
Senior Expertise, Curated Around the Challenge
JUYMO works through an invitation-only Executive Partner Network of experienced senior professionals, selected for their expertise, operational track record, and ability to deliver.
The right expertise is brought together around each engagement, extending JUYMO’s capabilities while maintaining senior involvement, lean structures, and execution continuity.
Founders
CEO
Mónica González
Mónica González is the creator of the Executive Strategy & Execution concept and Co-Founder & CEO of JUYMO.
Mónica brings more than 25 years of experience helping life sciences organizations transform strategy into operational execution across complex global healthcare markets.
Throughout her career, Mónica has led commercialization, launch readiness, market expansion, operational transformation, and complex cross-functional execution across international organizations including Novocure, SOBI, Novo Nordisk, CSL Vifor Pharma, Recordati, and Sanofi.
Through these experiences, she identified a recurring challenge: strategy and execution were too often treated as separate disciplines. She developed Executive Strategy & Execution to maintain continuity between strategic intent, governance, leadership, and operational delivery. The concept became the foundation of the JUYMO operating model.
Alongside her corporate leadership experience, Mónica contributes to healthcare innovation as a mentor, strategic advisor, and board-level advisor supporting emerging healthcare ventures internationally.
At JUYMO, she anchors the commercialization and operational execution side of the model, focused on senior-led execution, accountability, and keeping strategy directly connected to delivery.
Creator of Executive Strategy & Execution
CDO
Juan A. Flores
Juan A. Flores is Co-Founder and CDO of JUYMO and an AI-enabled commercialization and digital transformation leader with more than 25 years of international experience.
Juan has led more than 650 digital, commercialization, omnichannel, and transformation initiatives globally.
His work spans AI-enabled commercialization, digital transformation, GEO, AI discoverability, omnichannel transformation, digital governance, and human-led AI operating models, focused on simplifying complexity and connecting strategy directly to operational execution.
Throughout his career, Juan has built and scaled global digital organizations, strengthened governance, and led transformation across complex international environments, including leadership roles at Novocure, Alexion, Siemens, and Oswald.
He is the author of Digital + Marketing and Vice Versa and AI + Marketing and Vice Versa. His work is guided by “Bringing Common Sense to the Common Knowledge” that digital & AI tools base their answers on, applying practical judgment to existing knowledge and technology to turn complexity into executable action.
At JUYMO, Juan anchors the AI-enabled, digital, and operational transformation side of the model, combining senior leadership, operational clarity, governance, and AI-enabled delivery.
AI-Enabled Commercialization & Digital Transformation Leader
Advisory Board
JUYMO Advisory Board brings together prominent industry leaders. We are currently formalizing these appointments and will announce our official board members shortly.
Commercial
Focusing on commercial scale and market expansion, this advisor brings extensive experience in commercialization strategies, global distribution, and driving sustainable revenue growth across key markets.
Medical
Guiding our clinical strategy and scientific integrity, this position provides high-level expertise in medical affairs, research collaboration, and translating complex science into impactful healthcare solutions.
Brand & Patient
Dedicated to amplifying patient advocacy and brand reputation, this advisor oversees market positioning, stakeholder trust, and ensuring that patient needs remain at the core of our brand trajectory.